Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 6;10(3):613.
doi: 10.3390/biomedicines10030613.

Predictive Value of Urinary Aquaporin 2 for Acute Kidney Injury in Patients with Acute Decompensated Heart Failure

Affiliations

Predictive Value of Urinary Aquaporin 2 for Acute Kidney Injury in Patients with Acute Decompensated Heart Failure

Ming-Jen Chan et al. Biomedicines. .

Abstract

Acute kidney injury (AKI) is frequently encountered in people with acute decompensated heart failure (ADHF) and is associated with increased morbidity and mortality. Early detection of a urinary biomarker of kidney injury might allow a prompt diagnosis and improve outcomes. Levels of urinary aquaporin 2 (UAQP2), which is also associated with several renal diseases, are increased with ADHF. We aimed to determine whether UAQP2 predicted AKI in patients with ADHF. We conducted a prospective observation study in the coronary care unit (CCU) in a tertiary care university hospital in Taiwan. Individuals with ADHF admitted to the CCU between November 2009 and November 2014 were enrolled, and serum and urinary samples were collected. AKI was diagnosed in 69 (36.5%) of 189 adult patients (mean age: 68 years). Area under the receiver operating characteristic curve (AUROC) of biomarkers was evaluated to evaluate the diagnostic power for AKI. Both brain natriuretic peptide and UAQP2 demonstrated acceptable AUROCs (0.759 and 0.795, respectively). A combination of the markers had an AUROC of 0.802. UAQP2 is a potential biomarker of AKI in CCU patients with ADHF. Additional research on this novel biomarker is required.

Keywords: acute decompensated heart failure; acute kidney injury; coronary care unit; urinary aquaporin 2.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Levels of serum BNP (a) and urine AQP2 (b) across KDIGO stages. Abbreviations: AQP2, aquaporin 2; BNP, brain natriuretic peptide; KDIGO, Kidney Disease: Improving Global Outcomes. Abbreviations: BNP, brain natriuretic peptide; UAQP2, urinary excretion of aquaporin 2; UCr, urine creatinine.
Figure 2
Figure 2
Receiver operating characteristic curves of BNP, UAQP2, and UAQP2/UCr discriminating (a) AKI and (b) composite of AKI stage 3 and in-hospital mortality. Abbreviations: BNP, brain natriuretic peptide; UAQP2, urinary excretion of aquaporin 2; UCr, urine creatinine.
Figure 3
Figure 3
Cumulative mortality rates during 180-day follow-up of patients, with stratification of the optimal cutoff of UAQP2 (a) and UAQP2/UCr (b). Abbreviations: UAQP2, urinary excretion of aquaporin 2; UCr, urine creatinine.

Similar articles

Cited by

References

    1. Ronco C., Haapio M., House A.A., Anavekar N., Bellomo R. Cardiorenal syndrome. J. Am. Coll. Cardiol. 2008;52:1527–1539. doi: 10.1016/j.jacc.2008.07.051. - DOI - PubMed
    1. Bagshaw S.M., Cruz D.N. Epidemiology of cardiorenal syndromes. Contrib. Nephrol. 2010;165:68–82. doi: 10.1159/000313746. - DOI - PubMed
    1. Heywood J.T., Fonarow G.C., Costanzo M.R., Mathur V.S., Wigneswaran J.R., Wynne J., Committee A.S.A. Investigators. High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: A report from the ADHERE database. J. Card. Fail. 2007;13:422–430. doi: 10.1016/j.cardfail.2007.03.011. - DOI - PubMed
    1. Doshi R., Dhawan T., Rendon C., Rodriguez M.A., Al-Khafaji J.F., Taha M., Win T.T., Gullapalli N. Incidence and implications of acute kidney injury in patients hospitalized with acute decompensated heart failure. Intern. Emerg. Med. 2020;15:421–428. doi: 10.1007/s11739-019-02188-z. - DOI - PubMed
    1. Ostermann M., Zarbock A., Goldstein S., Kashani K., Macedo E., Murugan R., Bell M., Forni L., Guzzi L., Joannidis M., et al. Recommendations on Acute Kidney Injury Biomarkers From the Acute Disease Quality Initiative Consensus Conference: A Consensus Statement. JAMA Netw. Open. 2020;3:e2019209. doi: 10.1001/jamanetworkopen.2020.19209. - DOI - PubMed

LinkOut - more resources